EN
Article 2.27 of Trans-Pacific Partnership (PTP) agreement, concerning the trade of products of modern biotechnology, cannot be interpreted in a way which would impose upon any of the Parties an obligation to adopt or amendment of laws, regulations or policies for the control of such products within its territory. This provision defines the behavior in the event of detection of occurrence, in a shipment of plants or plant products, of “low-level presence” of rDNA plant material. It does not apply, however, to a plant or plant products that is a medicine or medical products. This provision do not also apply to animals and products of animal origin.